AAPL 166.74 -4.13 (-2.41%)MSFT 107.48 -1.98 (-1.81%)FB 145.36 +0.33 (+0.23%)ZNGA 3.66 -0.08 (-2.01%)NVDA 147.91 -0.95 (-0.64%)WBA 79.09 -3.23 (-3.92%)GOOG 1049.8 -12.2 (-1.15%)PIH 5 -0.12 (-2.34%)
AAPL 166.74 -4.13 (-2.41%)MSFT 107.48 -1.98 (-1.81%)FB 145.36 +0.33 (+0.23%)ZNGA 3.66 -0.08 (-2.01%)NVDA 147.91 -0.95 (-0.64%)WBA 79.09 -3.23 (-3.92%)GOOG 1049.8 -12.2 (-1.15%)PIH 5 -0.12 (-2.34%)

Financial Summary GTXI Quote GTx Inc.

GTx Inc. Quote

GTx Inc. (GTXI)

1.20 -0.01 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol GTXI
Price 1.20
Beta 1.54
Vol Avg 119.86 K
Mkt cap 423.33 M
Shares 17
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -107.14% Strong Sell
ROA -61.86% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity 21.05% Neutral
P/E -0.68
P/B 0.54 Buy
Company Profile

CEO

Marc S. Hanover

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Capital Market

Description

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.